We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
(+10%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$5.37M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.54M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$2.12M |
| 5 |
NVIDIA
NVDA
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$4.62M |
| 3 |
Oaktree Specialty Lending
OCSL
|
+$825K |
| 4 |
MGI
MoneyGram International, Inc. New
MGI
|
+$627K |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$562K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.18% |
| 2 | Technology | 15.3% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Industrials | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLS
1076
DELISTED
Apellis Pharmaceuticals
APLS
| $20.4K | ﹤0.01% |
224
-52
| -19% | -$4.49K |
|
1077
Littelfuse
LFUS
$11.6B
| $20.4K | ﹤0.01% |
70
+1
| +1% | +$262 |
|
1078
DigitalBridge
DBRG
$2.95B
| $20.4K | ﹤0.01% |
1,386
+242
| +21% | +$2.97K |
|
|
AGR
1079
DELISTED
Avangrid, Inc.
AGR
| $20.4K | ﹤0.01% |
541
+236
| +77% | +$9.26K |
|
1080
Vaxcyte
PCVX
$8.64B
| $20.4K | ﹤0.01% |
408
+81
| +25% | +$3.84K |
|
1081
Zurn Elkay Water Solutions
ZWS
$8.53B
| $20.2K | ﹤0.01% |
752
+45
| +6% | +$1.02K |
|
1082
Adtran
ADTN
$616M
| $20.2K | ﹤0.01% |
1,920
+1,892
| +6,757% | +$18.8K |
|
1083
Huntington Ingalls Industries
HII
$12.8B
| $20.2K | ﹤0.01% |
89
+36
| +68% | +$7.47K |
|
1084
Ferguson
FERG
$49.8B
| $20.1K | ﹤0.01% |
128
| – | – |
|
1085
WisdomTree US Total Dividend Fund
DTD
$1.69B
| $20.1K | ﹤0.01% |
324
| – | – |
|
1086
ARK Genomic Revolution ETF
ARKG
$1.73B
| $20.1K | ﹤0.01% |
590
-7
| -1% | -$220 |
|
1087
Jones Lang LaSalle
JLL
$16.7B
| $20.1K | ﹤0.01% |
129
+85
| +193% | +$12.1K |
|
1088
RPC Inc
RES
$1.3B
| $19.9K | ﹤0.01% |
2,788
-594
| -18% | -$4.35K |
|
1089
Turkcell
TKC
$4.79B
| $19.9K | ﹤0.01% |
5,583
-216
| -4% | -$906 |
|
|
THR
1090
DELISTED
Thermon Group Holdings
THR
| $19.9K | ﹤0.01% |
748
-16
| -2% | -$371 |
|
1091
Telefônica Brasil
VIV
$19.2B
| $19.9K | ﹤0.01% |
2,176
+526
| +32% | +$4.4K |
|
1092
Valley National Bancorp
VLY
$8.04B
| $19.9K | ﹤0.01% |
2,563
-153
| -6% | -$1.22K |
|
|
ALX
1093
Alexander's
ALX
$1.41B
| $19.9K | ﹤0.01% |
108
+72
| +200% | +$13K |
|
1094
Wabash National
WNC
$527M
| $19.8K | ﹤0.01% |
774
+57
| +8% | +$1.4K |
|
1095
First Financial Bankshares
FFIN
$4.97B
| $19.8K | ﹤0.01% |
696
+372
| +115% | +$10.6K |
|
1096
Glacier Bancorp
GBCI
$6.35B
| $19.8K | ﹤0.01% |
636
+157
| +33% | +$5.18K |
|
1097
Xtrackers MSCI EAFE High Dividend Yield Equity ETF
HDEF
$2.36B
| $19.8K | ﹤0.01% |
858
| – | – |
|
1098
Gen Digital
GEN
$17.5B
| $19.7K | ﹤0.01% |
1,061
+791
| +293% | +$13.8K |
|
1099
PJT Partners
PJT
$4.38B
| $19.6K | ﹤0.01% |
282
-18
| -6% | -$1.24K |
|
1100
HF Sinclair
DINO
$14.5B
| $19.6K | ﹤0.01% |
439
+28
| +7% | +$1.22K |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.
- Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
- Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
- Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
- Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
- Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
- Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.
Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.